Effect of Statin Therapy on Sepsis-related Mortality in Intensive Care Unit Patients - Trial NCT06354452
Access comprehensive clinical trial information for NCT06354452 through Pure Global AI's free database. This phase not specified trial is sponsored by Hospital de Granollers and is currently Completed. The study focuses on Sepsis,Septic Shock. Target enrollment is 59578 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Person-level linkage of the database looking for relationship with sepsis survival and previous intake of certain drug families and previous dependence on health services.
Observational
other
Sponsor & Location
Hospital de Granollers
Timeline & Enrollment
N/A
Jan 01, 2018
Jan 31, 2020
Primary Outcome
Death due to sepsis
Summary
The average age of patients with sepsis has increased in recent years in parallel with the
 incidence of sepsis. Many of these patients are frail and require various medications for the
 treatment of their chronic diseases. Common treatments, including e.g. sarcopenic drugs
 (statins, sulphonylureas, methyglinides), antioxidants that prevent sarcopenia (allopurinol)
 or immunoregulators (corticosteroids) may influence the survival and functional prognosis of
 these patients. Knowing which drugs influence sepsis survival and to what degree patients who
 survive sepsis have functional deterioration and increased comorbidity and which modifiable
 factors limit this may be essential.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06354452
Non-Device Trial